Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain June 24, 2025
- 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
- Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
- Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies February 19, 2025
- The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Molecular Diagnostics for Cancer Grows, Fueled by NGS-based Testing
Cancer diagnostics is a highly dynamic field that consists of various types of platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable accurate diagnosis as well as prognosis evaluation, which are important for treatment decisions. In 2019, the market for molecular cancer diagnostics, including histology and assays, reached $1,600 million, increasing 11.5% over […]
Clinical Labs are a 120+ Billion-Dollar Industry Globally
The global market for clinical laboratory services is estimated at $121.5 billion for 2019. This is up 2.9% from the estimated value in 2010 of $93.9 billion, according to a new Kalorama Information report. (https://kaloramainformation.com/product/clinical-laboratory-services-market-5th-edition/ ) Growth is driven by an aging population, a growing incidence of chronic diseases, but it is more than that. The […]
State of Mass Spectrometry in Clinical Labs
February 3, 2020 — For years, mass spectrometry found extensive use as a valuable analytical tool in industries ranging from chemical processing to drug discovery and development. Now the technology has transitioned into the clinical lab, with the commercialization of mass spectrometry platforms for microbial identification. In the clinical setting, mass spectrometry has gained attention as […]
Roche and Meridian Among Vendors with 2019-nCoV-related IVD products; FDA Steps in.
Major IVD vendors, especially those common in reverse transcription PCR (RT-PCR), went right to work in the recent coronavirus outbreak. This as the FDA announced plans to make emergency test deployment easier. The recent novel coronavirus, responsible for thousands of infections and over 170 deaths in the Hubei province in China at the time of […]
Barbershop Point of Care Testing? Study Shows it Might Be Effective
Point-of-care has potential to reach patients who may not even be aware they are patients, as evidenced by a recent study in a major journal that documented an unusual point-of-care venue: barbershops were found to be effective locations for on-the-spot testing of black men for hemoglobin A1c (HbA1c), according to a study published January 27 […]
AI in Healthcare, Nearly 2 Billion and Growing
Kalorama Information’s report, The Market for Artificial Intelligence (AI) in Healthcare, quantifies the opportunity and future market opportunity for AI in healthcare, already an almost two-billion-dollar market, with applications in workflow and population health, drug discovery and emerging applications in diagnostics and other areas. The Market for Artificial Intelligence (AI) in Healthcare In the United […]
New Report Focuses on NASH Market Opportunity
It’s no surprise that many pharmaceutical companies are developing treatments for a disease affecting millions with no current therapy. That disease is Non-alcoholic fatty liver disease (NAFLD). NASH is a lifestyle disease (obesity and lack of exercise) and is distinct from other fatty liver diseases caused by alcohol abuse or medication side effects. The symptoms […]
NT-proBNP comes of age for preoperative prediction of CV risks
From www.labpulse.com December 24, 2019 — Testing blood for N-terminal pro b-type natriuretic peptide (NT-proBNP) appears to have value as a preoperative test to predict risk of cardiovascular (CV) events, according to a study published December 24 online in Annals of Internal Medicine. The results may prompt a rethink of cardiology guidelines, which currently do not advise […]
Karius Test Demonstrates Ability To Detect Bloodstream Infections In Pediatric Patients With Cancer Before Symptoms Develop
Karius, a life sciences company, announced today that JAMA Oncology published a clinical study showing that the Karius Test detected bloodstream infections before the onset of clinical symptoms in high-risk pediatric patients with relapsed or refractory leukemia. The study was performed by researchers at St. Jude Children’s Research Hospital and provides the first evidence that the Karius Test […]
The Promising Growth of the Live Cell Imaging Market in 2019
Live cell imaging technologies have become an essential component of life science research on a global scale. Over the years, live cell imaging technologies have become easier to use for customers to conduct their research, such as drug discovery. Also, the market’s consumables and aftermarket products have experienced an increase in demand due to their […]